Stay updated with breaking news from Tim Bertram. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WINSTON-SALEM, N.C., March 28, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney
One of Winston-Salem’s newest publicly traded companies, ProKidney Corp., continued Tuesday in a pattern of reporting a lower quarterly loss.
WINSTON-SALEM, N.C., March 28, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage...
WINSTON-SALEM, N.C., March 28, 2023 -- ProKidney Corp. , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease , today announced financial results for the... | March 28, 2023
WINSTON-SALEM, N.C., March 03, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics...